Cargando…
The impact of reclassification by the 2022 ACR/EULAR classification criteria on risk factors for relapse in patients with ANCA-associated vasculitis
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Oxford University Press
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10690075/ https://www.ncbi.nlm.nih.gov/pubmed/38045999 http://dx.doi.org/10.1093/ckj/sfad225 |
| _version_ | 1785152485938167808 |
|---|---|
| author | van Leeuwen, Jolijn R Hafemann, Sophia van der Boog, Paul van der Woude, Diane Rabelink, Ton Teng, Y K Onno |
| author_facet | van Leeuwen, Jolijn R Hafemann, Sophia van der Boog, Paul van der Woude, Diane Rabelink, Ton Teng, Y K Onno |
| author_sort | van Leeuwen, Jolijn R |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10690075 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Oxford University Press |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-106900752023-12-02 The impact of reclassification by the 2022 ACR/EULAR classification criteria on risk factors for relapse in patients with ANCA-associated vasculitis van Leeuwen, Jolijn R Hafemann, Sophia van der Boog, Paul van der Woude, Diane Rabelink, Ton Teng, Y K Onno Clin Kidney J Letter to the Editor Oxford University Press 2023-09-07 /pmc/articles/PMC10690075/ /pubmed/38045999 http://dx.doi.org/10.1093/ckj/sfad225 Text en © The Author(s) 2023. Published by Oxford University Press on behalf of the ERA. https://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial License (https://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com |
| spellingShingle | Letter to the Editor van Leeuwen, Jolijn R Hafemann, Sophia van der Boog, Paul van der Woude, Diane Rabelink, Ton Teng, Y K Onno The impact of reclassification by the 2022 ACR/EULAR classification criteria on risk factors for relapse in patients with ANCA-associated vasculitis |
| title | The impact of reclassification by the 2022 ACR/EULAR classification criteria on risk factors for relapse in patients with ANCA-associated vasculitis |
| title_full | The impact of reclassification by the 2022 ACR/EULAR classification criteria on risk factors for relapse in patients with ANCA-associated vasculitis |
| title_fullStr | The impact of reclassification by the 2022 ACR/EULAR classification criteria on risk factors for relapse in patients with ANCA-associated vasculitis |
| title_full_unstemmed | The impact of reclassification by the 2022 ACR/EULAR classification criteria on risk factors for relapse in patients with ANCA-associated vasculitis |
| title_short | The impact of reclassification by the 2022 ACR/EULAR classification criteria on risk factors for relapse in patients with ANCA-associated vasculitis |
| title_sort | impact of reclassification by the 2022 acr/eular classification criteria on risk factors for relapse in patients with anca-associated vasculitis |
| topic | Letter to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10690075/ https://www.ncbi.nlm.nih.gov/pubmed/38045999 http://dx.doi.org/10.1093/ckj/sfad225 |
| work_keys_str_mv | AT vanleeuwenjolijnr theimpactofreclassificationbythe2022acreularclassificationcriteriaonriskfactorsforrelapseinpatientswithancaassociatedvasculitis AT hafemannsophia theimpactofreclassificationbythe2022acreularclassificationcriteriaonriskfactorsforrelapseinpatientswithancaassociatedvasculitis AT vanderboogpaul theimpactofreclassificationbythe2022acreularclassificationcriteriaonriskfactorsforrelapseinpatientswithancaassociatedvasculitis AT vanderwoudediane theimpactofreclassificationbythe2022acreularclassificationcriteriaonriskfactorsforrelapseinpatientswithancaassociatedvasculitis AT rabelinkton theimpactofreclassificationbythe2022acreularclassificationcriteriaonriskfactorsforrelapseinpatientswithancaassociatedvasculitis AT tengykonno theimpactofreclassificationbythe2022acreularclassificationcriteriaonriskfactorsforrelapseinpatientswithancaassociatedvasculitis AT vanleeuwenjolijnr impactofreclassificationbythe2022acreularclassificationcriteriaonriskfactorsforrelapseinpatientswithancaassociatedvasculitis AT hafemannsophia impactofreclassificationbythe2022acreularclassificationcriteriaonriskfactorsforrelapseinpatientswithancaassociatedvasculitis AT vanderboogpaul impactofreclassificationbythe2022acreularclassificationcriteriaonriskfactorsforrelapseinpatientswithancaassociatedvasculitis AT vanderwoudediane impactofreclassificationbythe2022acreularclassificationcriteriaonriskfactorsforrelapseinpatientswithancaassociatedvasculitis AT rabelinkton impactofreclassificationbythe2022acreularclassificationcriteriaonriskfactorsforrelapseinpatientswithancaassociatedvasculitis AT tengykonno impactofreclassificationbythe2022acreularclassificationcriteriaonriskfactorsforrelapseinpatientswithancaassociatedvasculitis |